drugset

drugset / Trial / NCT00833911

An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee

NCT00833911 ↗

Phase 3 Completed 392 enrolled Labopharm Inc.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to collect information regarding the long-term (6 and 12 months) safety of Tramadol HCl Once-A-Day(OAD) 300 mg.

Timeline

Start: 2003-04
Primary completion: 2004-07
Completion: 2004-07

Publications

Results Mongin G. Tramadol extended-release formulations in the management of pain due to osteoarthritis. Expert Rev Neurother. 2007 Dec;7(12):1775-84. doi: 10.1586/14737175.7.12.1775.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tramadol	Other / unclassified	300 mg	—

Indications